Chlamydia trachomatis remains one of the most prevalent sexually transmitted infections (STIs) globally, driving a continuous need for medical advancement and accessible healthcare. As diagnostic technologies evolve and public health awareness rises, the Chlamydia Infection Treatment Market is witnessing significant shifts. From the rise of rapid point-of-care testing to the challenges of...